Navigation Links
MedImmune's Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
Date:8/23/2007

Native American infants, with an overall incidence and severity of adverse events (AEs) that were similar between the motavizumab and the placebo groups. The mortality rates were not statistically different between groups (0.4 percent in the placebo arm, n=2 and 0.3 percent in the motavizumab arm, n=3) and were not considered to be related to the study drug. As was suggested in the pivotal Phase 3 trial conducted in high-risk, preterm infants, rates of hypersensitivity related skin rashes within two days of dosing were seen in about one percent of treated children in the motavizumab group.

MedImmune's Commitment to RSV Prevention

MedImmune is a world leader in the development of innovative therapeutic biologic products to prevent RSV disease. In 1996, MedImmune launched the first anti-RSV drug, RespiGam(R) (respiratory syncytial virus immune globulin intravenous (human) (RSV-IGIV)), which was a polyclonal antibody administered via four-hour intravenous infusion. In 1998, MedImmune introduced Synagis, which was a significant product improvement as a monthly intramuscular injection for the prevention of severe RSV, as well as being the first MAb to receive U.S. Food and Drug Administration (FDA) approval for an infectious disease. With the development of motavizumab, MedImmune continues to reinforce its commitment to developing anti-RSV products. In a head-to-head comparative Phase 3 trial with Synagis, motavizumab met its primary endpoint of reducing RSV-related hospitalizations in high-risk pediatric patients and met its secondary endpoint of reducing medically attended, outpatient respiratory tract infections in that patient group. MedImmune is also developing a small-molecule product candidate to prevent RSV as well as a vaccine against RSV, both of which are in Phase 1 clinical trials.

About RSV

Each year, up to 125,000 infants in the U.S. are hospitalized with severe RSV infections, the leading cause of lower respiratory tract infections
'/>"/>

SOURCE MedImmune, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
2. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
3. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
4. Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke
5. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
6. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
7. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
8. Pivotal Phase III Trial Showed Promacta (eltrombopag olamine) Raised Platelet Counts and Reduced Bleeding in Patients With Chronic ITP
9. Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have Reduced Potential to Develop Resistance to Panacos Bevirimat
10. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
11. Data Suggest Cymbalta Reduced Severity of Night Pain in Patients with Diabetic Nerve Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... 2015  MiMedx Group, Inc. (NASDAQ: MDXG ... amniotic tissue and patent-protected processes to develop and ... Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and ... the multiple inaccuracies in the press release issued ... recent rulings from the Patent Trial and Appeal ...
(Date:8/27/2015)...  Hill-Rom Holdings, Inc., (NYSE: HRC ) invites ... Morgan Stanley Global Healthcare Conference on September 16, 2015, ... to listen to the live discussion via the internet ... https://cc.talkpoint.com/morg007/091615a_ae/?entity=49_UCJPU8N . A recorded replay of ... conclusion of the live event and accessible via the ...
(Date:8/27/2015)... -- Major pharmaceutical and medical device companies and leading law ... Philadelphia on Oct. 20, discussing issues surrounding ... of HB Litigation Conferences has announced. To ... http://litigationconferences.com/?p=31886 The program is co-chaired by ... Michelle Hart Yeary of Dechert LLP. ...
Breaking Medicine Technology:MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 2MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 3MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 4Pharmaceutical, Medical Device Law Seminar Features In-House, Outside Counsel 2Pharmaceutical, Medical Device Law Seminar Features In-House, Outside Counsel 3
... The World Health Organization (WHO) has granted prequalification to ... immunization of infants and children from 6 weeks through ... otitis media caused by the 13 pneumococcal serotypes (1, ... 19A, 19F and 23F) contained in the vaccine. WHO ...
... Unilife Corporation ("Unilife" or "Company") (Nasdaq: UNIS ; ... financial results for the fiscal 2010 fourth quarter and year ... August 30, 2010. Management has scheduled a ... 30, 2010 (Tuesday, August 31 at 6.30 a.m. AEST) ...
Cached Medicine Technology:World Health Organization Grants Prequalification to Prevenar 13*, Pfizer's 13-valent Pneumococcal Conjugate Vaccine for Infants and Young Children 2World Health Organization Grants Prequalification to Prevenar 13*, Pfizer's 13-valent Pneumococcal Conjugate Vaccine for Infants and Young Children 3World Health Organization Grants Prequalification to Prevenar 13*, Pfizer's 13-valent Pneumococcal Conjugate Vaccine for Infants and Young Children 4World Health Organization Grants Prequalification to Prevenar 13*, Pfizer's 13-valent Pneumococcal Conjugate Vaccine for Infants and Young Children 5World Health Organization Grants Prequalification to Prevenar 13*, Pfizer's 13-valent Pneumococcal Conjugate Vaccine for Infants and Young Children 6World Health Organization Grants Prequalification to Prevenar 13*, Pfizer's 13-valent Pneumococcal Conjugate Vaccine for Infants and Young Children 7Unilife Corporation Schedules Fiscal 2010 Fourth Quarter and Year End Conference Call for Monday, August 30, 2010 2
(Date:8/27/2015)... ... August 27, 2015 , ... Mesa Community College ... 2,100 applicants worldwide, selected based on academic rigor, leadership and engagement, to receive a ... baccalaureate degree. , Sypher will receive a medallion and a $7,500 scholarship to assist ...
(Date:8/27/2015)... (PRWEB) , ... August 27, 2015 , ... ... of instruments available for quantitative PCR (qPCR) in the last decade. ... throughput and reduced operating costs. On the flipside, where do lab managers, technicians, ...
(Date:8/27/2015)... ... August 27, 2015 , ... In an article published ... in the city of New Orleans, highlighting a security firm that is tasked with ... a tech oriented entrepreneur who worked with the city to provide private security when ...
(Date:8/27/2015)... CA (PRWEB) , ... August 27, 2015 , ... ... plans to enter the exploding legal marijuana industry with the launch of its ... consumers of legal marijuana to order products from their smart phones and tablets. ...
(Date:8/27/2015)... ... August 27, 2015 , ... Dr. Jennifer Arnold, co-star of “The ... at CURE® magazine’s 3rd Annual MPN Heroes™ recognition event on Friday, Dec. ... hundreds of attendees honoring eight heroes who have made significant contributions in the field ...
Breaking Medicine News(10 mins):Health News:Mesa Community College Graduate Andrew Sypher Receives Hites Transfer Scholarship 2Health News:Mesa Community College Graduate Andrew Sypher Receives Hites Transfer Scholarship 3Health News:Douglas Scientific® Webinar Outlines Comparisons of Varied qPCR Instruments 2Health News:Douglas Scientific® Webinar Outlines Comparisons of Varied qPCR Instruments 3Health News:Article on New Orleans Security Force Highlights the Abilities and Flexibility of Private Security, says Spear Security Inc. 2Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 2Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 3Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 4Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 5Health News:Dr. Jennifer Arnold of ‘The Little Couple’ to Keynote 3rd Annual MPN Heroes™ Recognition Event in Orlando 2Health News:Dr. Jennifer Arnold of ‘The Little Couple’ to Keynote 3rd Annual MPN Heroes™ Recognition Event in Orlando 3Health News:Dr. Jennifer Arnold of ‘The Little Couple’ to Keynote 3rd Annual MPN Heroes™ Recognition Event in Orlando 4
... technique known as transcendental meditation may decrease blood ... coronary // heart disease, according to a report ... Internal Medicine, one of the JAMA/Archives journals. ... Vedic tradition in India, is taught through a ...
... seems to be a connection between triple measles, mumps and rubella ... 1998 says. ,Thus Doctor’s who has done a health ... of professional misconduct for their act. ,A survey ... 1995-96 and only 82% in the year 2002-03 were taken the ...
... and money. It has been one of the leading causes of ... that the number of cases rose by 6% last year //. ... the Royal Environmental Health Institute of Scotland (Rehis) said that this ... He said that the number of cases accounted to about 70,000 ...
... the fungus implicated in recent eye infections among soft ... of cases of keratitis// (corneal swelling and inflammation), according ... Ophthalmology, one of the JAMA/Archives journals. , ,Infections ... structure of the eye and the patient's vision, according ...
... in Sagar district of Madhya Pradesh and more than 50 people ... with the Human Immunodeficiency Virus (HIV) in Sagar, 180 km from ... one woman, 16 men and two eunuchs, health officials said. ... in March, 10 HIV cases came to light in April and ...
... meeting on the Codex Committee on Nutrition and Food ... first Asian host for the meeting focusing on international ... said. ,Dr. Charal Trinvuthipong, advisor to Thailand's ... 169 member countries of Codex would participate in the ...
Cached Medicine News:Health News:Meditation may Improve Cardiac Risk Factors in Patients with Coronary Heart Disease 2Health News:Reports Characterize Fungal Eye Infections Among Soft Contact Lens Wearers 2Health News:Reports Characterize Fungal Eye Infections Among Soft Contact Lens Wearers 3
Designed to give maximum drying area while taking up minimal bench space....
Used to remove wrinkles from sections and for reorientating embedded tissue....
Compact instrument that quickly dries racks of slides using warm air....
Liquichek Blood Gas Plus CO-Oximeter Control (IL Synthesis Series) is a combination control for use in monitoring the performance of blood gas, ion-selective electrode, biosensor and CO-Oximetry anal...
Medicine Products: